Home › Colorectal Cancer › Illinois › Arlington Heights
Pag-aaral pangklinika para sa Colorectal Cancer sa Arlington Heights, IL
Isang pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington Heights. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Family Communications After Genetic Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Alexian Brothers Medical Center, Elk Grove Village · 6 mi ang layo
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Nagre-recruitPhase 1
- Illinois Cancer Specialists, Arlington Heights
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Nagre-recruitPhase 2
- Illinois Cancer Specialists, Arlington Heights
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Nagre-recruitObservasyonal na pag-aaral
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Gastroenterology and Internal Medicine Specialists, Lake Barrington · 12 mi ang layo
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Arlington Heights
- Non-Small Cell Lung Cancer12 pag-aaral
- Kanser sa Baga9 pag-aaral
- Kanser sa Suso7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Metastatic Cancer6 pag-aaral
- Ulcerative Colitis6 pag-aaral
- Colon Cancer6 pag-aaral
- Kanser sa Ovary5 pag-aaral
- Obesity5 pag-aaral
- Overweight5 pag-aaral
- Kanser sa Prostate3 pag-aaral
- Mga Kondisyon ng Balat3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.